Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Trinity Bio ADR (TRIB)

Trinity Bio ADR (TRIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Trinity Biotech plc Announces WHO Approval for Manufacturing Transfer of HIV Tests as Part of Comprehensive Transformation Plan Quiver Quantitative, Inc. - Wed Dec 18, 8:20PM CST

Trinity Biotech updates on its transformation plan, announcing WHO approval for offshore HIV test manufacturing, enhancing growth potential.Quiver AI SummaryTrinity Biotech plc, a biotechnology company...

TRIB : 0.8800 (+10.00%)
Trinity Biotech plc Reports Q3 2024 Revenue Growth of 3% to $15.2 Million, Driven by Strong TrinScreen HIV Product Demand Quiver Quantitative, Inc. - Fri Nov 15, 6:24PM CST

Trinity Biotech reported Q3 2024 revenue of $15.2 million, with a 3% year-over-year increase and strong Point-of-Care sales.Quiver AI SummaryTrinity Biotech plc reported a 3% year-on-year revenue growth...

TRIB : 0.8800 (+10.00%)
Trinity Biotech Announces Quarter 1 2022 Financial Results Globe Newswire - Thu Jun 30, 2022

DUBLIN, Ireland, June 30, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for...

TRIB : 0.8800 (+10.00%)
Trinity Biotech plc to Announce First Quarter Fiscal Year 2022 Financial Results Globe Newswire - Wed Jun 29, 2022

Conference Call Scheduled for June 30, 2022 at 11:00 am EASTERN...

TRIB : 0.8800 (+10.00%)
Trinity Biotech Announces CE Mark of its 10-Minute Covid-19 Antigen Test Globe Newswire - Fri May 20, 2022

DUBLIN, Ireland, May 20, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has achieved a CE Mark for its 10-minute Covid-19 antigen test. This...

TRIB : 0.8800 (+10.00%)
Trinity Biotech Announces the Successful Closing of its Strategic Investment and Partnership With The MiCo Group of South Korea Globe Newswire - Tue May 3, 2022

DUBLIN, Ireland, May 03, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the...

TRIB : 0.8800 (+10.00%)
Trinity Biotech Announces Quarter 4 and Fiscal Year 2021 Financial Results Globe Newswire - Mon Apr 11, 2022

DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for...

TRIB : 0.8800 (+10.00%)
Trinity Biotech Announces A $45 Million Strategic Investment And Partnership With The MiCo Group of South Korea Globe Newswire - Mon Apr 11, 2022

DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading global diagnostic company (“Trinity Biotech” or the...

TRIB : 0.8800 (+10.00%)
Trinity Biotech Announces the World Health Organisation Approval Of TrinScreen™ HIV Globe Newswire - Mon Feb 14, 2022

DUBLIN, Ireland, Feb. 14, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has received approval for its new HIV screening product,...

TRIB : 0.8800 (+10.00%)
Trinity Biotech Announces The Successful Closing of its Debt Refinancing Globe Newswire - Thu Jan 27, 2022

DUBLIN, Ireland, Jan. 27, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for...

TRIB : 0.8800 (+10.00%)

Barchart Exclusives

Navigating Uncertainty: What I'm Watching In The Grain Markets To Wrap Up 2024 Barchart - 20 minutes ago
From Brazil's economic woes to the future of biofuels, there is something for everyone as we end the year. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot